Register

COURSE DESCRIPTION: 
Please join us for a discussion on intermediate risk: “Update on Alzheimer’s Disease” with G. Peter Gliebus, M.D., FAAN.  Dr. Gliebus will describe the timeline of Alzheimer’s disease pathogenesis, interpret and employ AD diagnostic tests in practice and explore the developing Alzheimer’s disease treatment landscape.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents,  Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Describe the timeline of Alzheimer’s disease pathogenesis.
• Interpret and employ AD diagnostic tests in practice.
• Explore the developing Alzheimer’s disease treatment landscape.

G. Peter Gliebus, M.D., FAAN 
Director, Cognitive and Behavioral Neurology Program
Baptist Health - Marcus Neurosciences Institute
Associate Professor of Neurology
Florida Atlantic University 
Boca Raton, Florida
 

G. Peter Gliebus, M.D., FAAN, faculty for this educational activity, indicated that he is a speaker for Eisai Pharmaceuticals. Dr. Gliebus has indicated that the presentation or discussion will include off-label or unapproved product usage.  All of the relevant financial relationships listed for these individuals have been mitigated.

John F. Rubin, M.D., FACP, director of this educational activity, has indicated that he is a shareholder in AstraZeneca and Bristol-Myers Squibb. All of the relevant financial relationships listed for this individual have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.